Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NDUFAF1 is a mitochondrial protein that acts as an essential assembly factor for NADH:ubiquinone oxidoreductase (complex I), the largest enzyme of the mitochondrial electron transport chain[2][1]. It assists in the stepwise integration of various subunits and stabilizes key assembly intermediates, specifically by locking the ND3 subunit in a conformation that prevents misassembly[1][3]. NDUFAF1 forms part of early assembly intermediates with other proteins (such as ACAD9 and ECSIT) and has been shown to interact structurally with both protein and lipid components critical to mitochondrial architecture. Genetic mutations of NDUFAF1 in humans lead to complex I deficiencies manifesting as varied and severe diseases, including lethal neonatal mitochondrial disease, cardiomyopathy, and neurodegeneration. Currently, there are no known direct pharmacological agents targeting NDUFAF1, but its function is central to maintaining mitochondrial respiratory function and cellular energy homeostasis[2][1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase (ubiquinone) 1 alpha subcomplex assembly factor 1 (NDUFAF1).